Filing Details

Protalix BioTherapeutics Inc

(Name of Issuer)

Common Stock 

(Title of Class of Securities)

74365A309    

(CUSIP Number)

12/04/2020 

(Date of Event Which Requires Filing of this Statement)

CUSIP No. 74365A309

13G

Page   of     

1

NAME OF REPORTING PERSONS

  Burrage Capital Management

2

CHECK THE APPROPRIATE BOX IF MEMBER OF A GROUP

(a)  ☐

(b)  ☐  

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 United States of America

5

SOLE VOTING POWER

 2,470,332

NUMBER OF

6

SHARED VOTING POWER

SHARES

BENEFICIALLY

 0

OWNED BY

7

SOLE DISPOSITIVE POWER

EACH REPORTING

PERSON WITH

 2,470,332

8

SHARED DISPOSITIVE POWER

0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 2,470,332

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

☐

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 7.41% (based upon 33,336,709 Shares)

12

TYPE OF REPORTING PERSON

(a)

Name of Issuer: Protalix BioTherapeutics Inc

(b)

Address of Issuer: 2 Snunit Street, Science Park PO Box 455, Carmiel, 20100, Israel

Item 2(a). 

Name of Person Filing: Burrage Capital Management LLC

Item 2(b)  

Address of Principal Business Office or, if none, Residence: 314 Commonwealth Ave, #4, Boston, MA 02115

Item 2(c).

Citizenship or Place of Organization: Delaware

Item 2(d).

Title of Class of Securities: Common Stock

Item 2(e). 

CUSIP Number: 74365A309

(a)

☐

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b)

☐

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c)

☐

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d)

☐

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e)

X

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)

☐

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)

☐

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

(h)

☐

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

☐

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

☐

Group, in accordance with §240.13d-1(b)(1)(ii)(J).

a)

Amount beneficially owned: 2,470,332

b)

Percent of class: 7.41%

c)

Number of shares as to which the Reporting Person has:

(i) Sole power to vote or to direct the vote: 2,470,332

(ii) Shared power to vote or to direct the vote: 0

(iii) Sole power to dispose or to direct the disposition of: 2,470,332

(iv) Shared power to dispose or to direct the disposition of: 0

Item 5.

Ownership of 5 Percent or Less of a Class.

Item 6.

Ownership of More than 5 Percent on Behalf of Another Person.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Item 8.

Identification and Classification of Members of the Group.

Item 9.

Notice of Dissolution of Group.

Item 10.

Certifications.

Date: February 12, 2021

By:

/s/ Jeff Crispen

 Jeff Crispen, CFO/COO